Wednesday, February 23, 2011 5:20:16 PM
SCI Engineered Materials, Inc. Announces Date for Release of Fourth Quarter and Full Year 2010 Results
Marketwire - Feb 23 at 15:28
Company Symbols: NASDAQ-OTCBB:SCIA
COLUMBUS, OH -- (MARKET WIRE) -- 02/23/11 -- SCI Engineered Materials, Inc. (OTCBB: SCIA), develops and commercializes technologies and also manufactures ceramics and metals for advanced applications in the physical vapor deposition industry. Today the company announced it plans to release fourth quarter and full year 2010 financial results after the market closes on Monday, February 28, 2011.
About SCI Engineered Materials, Inc.
SCI Engineered Materials, Inc. develops, commercializes technologies and manufactures ceramics and metals for advanced applications in the physical vapor deposition industry such as photonics, solar, thin film batteries, and semiconductors. SCI Engineered Materials, Inc. is a global materials supplier with clients in more than 40 countries. Additional information is available at http://www.sciengineeredmaterials.com.
Contact:
Robert Lentz
(614) 876-2000
Source: SCI Engineered Materials, Inc.
NEED Investment Ideas...??
http://investorshub.advfn.com/boards/board.aspx?board_id=10347
Recent SCIA News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 06:28:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/14/2024 06:27:43 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/12/2024 10:28:57 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 03:59:58 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/09/2024 01:01:34 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/27/2023 12:01:28 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 07/28/2023 12:01:08 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM